Implant Sciences awarded order for 122 explosives trace detectors

Implant Sciences Corporation (OTCQB: IMSC) has received a previously unannounced order from the Canadian Air Transport Security Authority (CATSA) for up to 122 of its industry-leading QS-B220 desktop explosives trace detectors, the company said.

These systems are planned to be deployed during the first half of 2016 (i.e., during Implant Sciences´ current fiscal year ending June 30) to a number of Canadian airports for passenger and baggage screening.

The QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCalâ„¢ internal automatic calibration system, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with ease of use.

Implant Sciences develops and makes advanced detection capabilities to counter and eliminate the ever-evolving threats from explosives and drugs. The company´s team of dedicated trace detection experts has developed proprietary technologies used in its commercial products, thousands of which have been sold across more than 70 countries worldwide.